EGFR and glioblastoma: Two commonly expressed tumor antigens in GBM include the epidermal growth factor receptor mutant (EGFRvIII) and the interleukin-13 receptor alpha 2 (IL-13Rα2), which are potential targets for the treatment of GBM2,3.